Moreover, previous studies have identified TNF-α as a potential predictive factor for response to therapy and overall disease progression during oncological treatment, specifically through modulation of the immunological response in the tumor microenvironment [6,7,8]. The gene discussed is TNF; the disease is neoplasm.